325 related articles for article (PubMed ID: 25586024)
21. A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA.
Liu Y; Ding S; Dietrich R; Märtlbauer E; Zhu K
Angew Chem Int Ed Engl; 2017 Feb; 56(6):1486-1490. PubMed ID: 28106348
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
[TBL] [Abstract][Full Text] [Related]
23. Synergistic Antibacterial Activity Between 1,4-Naphthoquinone and β-Lactam Antibiotics Against Methicillin-Resistant
Yap JKY; Tan SYY; Tang SQ; Thien VK; Chan EWL
Microb Drug Resist; 2021 Feb; 27(2):234-240. PubMed ID: 32589487
[No Abstract] [Full Text] [Related]
24. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
[TBL] [Abstract][Full Text] [Related]
25. Molecular Bases Determining Daptomycin Resistance-Mediated Resensitization to β-Lactams (Seesaw Effect) in Methicillin-Resistant Staphylococcus aureus.
Renzoni A; Kelley WL; Rosato RR; Martinez MP; Roch M; Fatouraei M; Haeusser DP; Margolin W; Fenn S; Turner RD; Foster SJ; Rosato AE
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795377
[TBL] [Abstract][Full Text] [Related]
26. Variation in synergistic activity by flavone and its related compounds on the increased susceptibility of various strains of methicillin-resistant Staphylococcus aureus to beta-lactam antibiotics.
Sato Y; Shibata H; Arai T; Yamamoto A; Okimura Y; Arakaki N; Higuti T
Int J Antimicrob Agents; 2004 Sep; 24(3):226-33. PubMed ID: 15325425
[TBL] [Abstract][Full Text] [Related]
27. Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon.
Périchon B; Courvalin P
Antimicrob Agents Chemother; 2006 Nov; 50(11):3622-30. PubMed ID: 16954318
[TBL] [Abstract][Full Text] [Related]
28. Structure-Activity Relationships of Daptomycin Lipopeptides.
Karas JA; Carter GP; Howden BP; Turner AM; Paulin OKA; Swarbrick JD; Baker MA; Li J; Velkov T
J Med Chem; 2020 Nov; 63(22):13266-13290. PubMed ID: 32687352
[TBL] [Abstract][Full Text] [Related]
29. 6,7-dihydroxyflavone dramatically intensifies the susceptibility of methicillin-resistant or -sensitive Staphylococcus aureus to beta-lactams.
Sato Y; Shibata H; Arakaki N; Higuti T
Antimicrob Agents Chemother; 2004 Apr; 48(4):1357-60. PubMed ID: 15047543
[TBL] [Abstract][Full Text] [Related]
30. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Akins RL; Rybak MJ
Antimicrob Agents Chemother; 2001 Feb; 45(2):454-9. PubMed ID: 11158740
[TBL] [Abstract][Full Text] [Related]
31. Beta-lactams against methicillin-resistant Staphylococcus aureus.
Guignard B; Entenza JM; Moreillon P
Curr Opin Pharmacol; 2005 Oct; 5(5):479-89. PubMed ID: 16095969
[TBL] [Abstract][Full Text] [Related]
32. Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.
Therien AG; Huber JL; Wilson KE; Beaulieu P; Caron A; Claveau D; Deschamps K; Donald RG; Galgoci AM; Gallant M; Gu X; Kevin NJ; Lafleur J; Leavitt PS; Lebeau-Jacob C; Lee SS; Lin MM; Michels AA; Ogawa AM; Painter RE; Parish CA; Park YW; Benton-Perdomo L; Petcu M; Phillips JW; Powles MA; Skorey KI; Tam J; Tan CM; Young K; Wong S; Waddell ST; Miesel L
Antimicrob Agents Chemother; 2012 Sep; 56(9):4662-70. PubMed ID: 22710113
[TBL] [Abstract][Full Text] [Related]
33. Anti-staphylococcal activity of a cyclic lipopeptide, C
Nam J; Alam ST; Kang K; Choi J; Seo MH
J Appl Microbiol; 2021 Jul; 131(1):93-104. PubMed ID: 33211361
[TBL] [Abstract][Full Text] [Related]
34. Synergy between Ursolic and Oleanolic Acids from Vitellaria paradoxa Leaf Extract and β-Lactams against Methicillin-Resistant Staphylococcus aureus: In Vitro and In Vivo Activity and Underlying Mechanisms.
Catteau L; Reichmann NT; Olson J; Pinho MG; Nizet V; Van Bambeke F; Quetin-Leclercq J
Molecules; 2017 Dec; 22(12):. PubMed ID: 29258194
[TBL] [Abstract][Full Text] [Related]
35. Antibacterial and synergic effects of gallic acid-grafted-chitosan with β-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
Lee DS; Eom SH; Kim YM; Kim HS; Yim MJ; Lee SH; Kim DH; Je JY
Can J Microbiol; 2014 Oct; 60(10):629-38. PubMed ID: 25216286
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of newly generated short antimicrobial cationic lipopeptides against methicillin-resistant Staphylococcus aureus (MRSA).
Greber KE; Roch M; Rosato MA; Martinez MP; Rosato AE
Int J Antimicrob Agents; 2020 Mar; 55(3):105827. PubMed ID: 31634552
[TBL] [Abstract][Full Text] [Related]
37. Muropeptide signature of inhibitors of protein synthesis correlates with β-lactam synergism against methicillin-resistant Staphylococcus aureus.
Guignard B; Majcherczyk PA; Monachon C; Vouillamoz J; Moreillon P
Int J Antimicrob Agents; 2017 Jan; 49(1):53-61. PubMed ID: 27887965
[TBL] [Abstract][Full Text] [Related]
38. Polyamine effects on antibiotic susceptibility in bacteria.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
[TBL] [Abstract][Full Text] [Related]
39. N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus.
Turos E; Long TE; Konaklieva MI; Coates C; Shim JY; Dickey S; Lim DV; Cannons A
Bioorg Med Chem Lett; 2002 Aug; 12(16):2229-31. PubMed ID: 12127544
[TBL] [Abstract][Full Text] [Related]
40. Tetracyclic indolines as a novel class of β-lactam-selective resistance-modifying agent for MRSA.
Zhu Y; Cleaver L; Wang W; Podoll JD; Walls S; Jolly A; Wang X
Eur J Med Chem; 2017 Jan; 125():130-142. PubMed ID: 27657810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
